Skip to main content
MainBoardListed
Global Health Limited Logo

Global Health Limited IPO

Global Health Limited IPO

IPO Date :
Issue Price :
Allotment Date :
Listing Date :
List Price :
Lot Size:
Subscription:
Listed Price: ₹ 401.00 (+19.35%)

Global Health Limited's successfully completed its Initial Public Offering and commenced trading on 16-11-2022 at the NSE, BSE exchange. The company raised 6,56,41,952 Shares through this public offering, comprising 1,48,80,952 Shares in fresh capital and ₹1705.57 Cr through the Offer for Sale mechanism.

The IPO was priced within the band of ₹336 to ₹336, with minimum application lots of 44 shares. The offering attracted significant investor interest during its subscription period from 03-11-2022 to 07-11-2022.

Share allotment was finalized on 11-11-2022, distributing equity to successful applicants. The stock's subsequent listing marked a significant milestone in the company's corporate history, providing public market liquidity to shareholders.

Global Health IPO Details
Lot(s) Distribution

Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.

IPO Reservation
Global Health IPO Key Performance Indicator
Company Financials ( In Crores )

Global Health IPO About Company

Global Health Limited is one of the largest private multi-speciality tertiary care providers in North and East India, operating under the "Medanta" brand. The company specializes in cardiology, neurosciences, oncology, digestive sciences, orthopaedics, liver transplants, and kidney care. With hospitals in Gurugram, Indore, Ranchi, and Lucknow, it offers healthcare services across 30 medical specialities with over 1,300 doctors and 2,467 installed beds. Medanta’s Gurugram hospital was ranked India’s best private hospital from 2020 to 2022 and featured in Newsweek’s global hospital rankings. The company emphasizes clinical research, academic excellence, and advanced medical infrastructure. Its strong financial performance, presence in high-demand areas, and expansion into digital health contribute to its growth. Backed by experienced management and institutional investors, Global Health Limited continues to strengthen its position in India's healthcare sector.


Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."


Global Health IPO Strength Factors

NA


Global Health IPO Risk Factors

NA


Global Health IPO Lead Manager(s)

  • Kotak Mahindra Capital Company
  • Credit Suisse Securities (India) Private Limited
  • Jefferies India Private Limited
  • Jm Financial Limited

Global Health IPO Promoter(s)

  1. Dr. Naresh Trehan

Global Health IPO Company Details

Global Health Limited
Phone:
address:

Global Health IPO Registrar

Kfin Technologies Limited
Name:
Phone:

Global Health IPO FAQs